%PDF- %PDF-
Mini Shell

Mini Shell

Direktori : /var/www/html/sljcon/public/queen-of-rvaikti/cache/
Upload File :
Create Path :
Current File : /var/www/html/sljcon/public/queen-of-rvaikti/cache/a66a1db22225c620f2cd1192aa25e88b

a:5:{s:8:"template";s:9598:"<!DOCTYPE html>
<html lang="en">
<head>
<meta content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no" name="viewport"/>
<meta charset="utf-8"/>
<title>{{ keyword }}</title>
<link href="//fonts.googleapis.com/css?family=Playfair+Display%3A400%2C400italic%2C700%2C700italic%7CMerriweather%3A400%2C400italic%2C700%2C700italic&amp;ver=1.0" id="camille-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">.has-drop-cap:not(:focus):first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}.has-drop-cap:not(:focus):after{content:"";display:table;clear:both;padding-top:14px} html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}footer,header{display:block}a{background:0 0}a:active,a:hover{outline:0}@media print{*{color:#000!important;text-shadow:none!important;background:0 0!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}a[href^="#"]:after{content:""}}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:62.5%;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#428bca;text-decoration:none}a:focus,a:hover{color:#2a6496;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}ul{margin-top:0;margin-bottom:10px}.container{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}.row{margin-right:-15px;margin-left:-15px}.col-md-12,.col-md-6,.col-sm-12{position:relative;min-height:1px;padding-right:15px;padding-left:15px}@media (min-width:768px){.col-sm-12{float:left}.col-sm-12{width:100%}}@media (min-width:992px){.col-md-12,.col-md-6{float:left}.col-md-12{width:100%}.col-md-6{width:50%}} .container-fluid:after,.container-fluid:before,.container:after,.container:before,.row:after,.row:before{display:table;content:" "}.container-fluid:after,.container:after,.row:after{clear:both}@-ms-viewport{width:device-width}@font-face{font-family:Merriweather;font-style:italic;font-weight:400;src:local('Merriweather Italic'),local('Merriweather-Italic'),url(http://fonts.gstatic.com/s/merriweather/v21/u-4m0qyriQwlOrhSvowK_l5-eRZOf-c.ttf) format('truetype')}@font-face{font-family:Merriweather;font-style:italic;font-weight:700;src:local('Merriweather Bold Italic'),local('Merriweather-BoldItalic'),url(http://fonts.gstatic.com/s/merriweather/v21/u-4l0qyriQwlOrhSvowK_l5-eR71Wvf4jvk.ttf) format('truetype')}@font-face{font-family:Merriweather;font-style:normal;font-weight:400;src:local('Merriweather Regular'),local('Merriweather-Regular'),url(http://fonts.gstatic.com/s/merriweather/v21/u-440qyriQwlOrhSvowK_l5-fCZJ.ttf) format('truetype')}@font-face{font-family:Merriweather;font-style:normal;font-weight:700;src:local('Merriweather Bold'),local('Merriweather-Bold'),url(http://fonts.gstatic.com/s/merriweather/v21/u-4n0qyriQwlOrhSvowK_l52xwNZWMf_.ttf) format('truetype')} body{font-family:Arial,sans-serif;margin-top:0!important;background:#fff;font-size:14px;color:#000;line-height:25px;text-rendering:optimizeLegibility}a,a:focus{color:#ed7f6f;text-decoration:underline}a:hover{color:#000;text-decoration:none}a:focus{text-decoration:none;-webkit-touch-callout:none;-webkit-user-select:none;-khtml-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;outline-style:none;outline:0}header{background:#fff;background-repeat:no-repeat;background-position:top center}header .container{padding:0}header .col-md-12{display:table;height:200px}header .logo{font-size:16px}header .header-left{display:table-cell;vertical-align:middle;text-align:left;width:33.3333%;padding-left:15px}header .header-center{display:table-cell;vertical-align:middle;text-align:center;width:33.3333%}header .header-right{display:table-cell;vertical-align:middle;text-align:right;width:33.3333%;padding-right:15px}header .header-logo-center .header-center{min-width:0;text-align:center;width:40%}header .header-logo-center .header-left{width:30%}header .header-logo-center .header-right{width:30%}.header-menu-bg{z-index:10001;width:100%;background:#fff;border-bottom:1px solid rgba(0,0,0,.1)}.header-menu-bg.menu_black{background:#000;border-bottom:0}.header-menu{overflow:visible;font-size:12px;line-height:1.42857}.header-menu ul{margin:0;padding:0}.header-menu li{position:relative;display:block;float:left}.header-menu li a{color:rgba(0,0,0,.5);display:block;padding-right:15px;padding-left:15px;padding-top:22px;padding-bottom:22px;text-decoration:none;text-transform:uppercase}.header-menu-bg.menu_black .header-menu li a{color:#fff}.header-menu-bg.menu_black .header-menu li a:hover{color:rgba(255,255,255,.5)}.header-menu li a:hover{text-decoration:none;color:#ed7f6f}.header-menu-bg.menu_black .header-menu .menu-top-menu-container-toggle{color:#fff}.header-menu-bg.menu_black .header-menu .menu-top-menu-container-toggle+div{background:#000}.header-menu .menu-top-menu-container-toggle+div{float:left}.header-menu .menu-top-menu-container-toggle{float:left;display:none;color:#000;cursor:pointer;padding:22px;padding-left:0}.header-menu .menu-top-menu-container-toggle:hover{opacity:.5}.header-menu .menu-top-menu-container-toggle:after{content:"";display:inline-block;font-family:fontawesome;font-weight:400;font-size:14px}.container-fluid-footer{padding:0;background:#26292c}.container-fluid-footer>.row{margin:0}footer{padding:40px 0 80px;background-color:#1e1c1c;color:#fff}footer .container{padding-left:0;padding-right:0}footer .container>.row{margin:0}footer .footer-menu{font-size:12px;text-transform:uppercase;margin-bottom:30px;letter-spacing:1px}footer .footer-menu>div{border-bottom:1px solid rgba(255,255,255,.1);padding-bottom:30px;text-align:center}footer .footer-copyright{text-align:center;font-size:14px;color:rgba(255,255,255,.4)}@media (max-width:1024px){header .header-center,header .header-left,header .header-right{display:block}header .col-md-12{height:auto!important;display:block}.header-logo-center .header-center{padding:20px}header>.container>.row{margin:0}header>.container{padding:0}header .logo{display:block}header .header-center,header .header-left,header .header-logo-center .header-left,header .header-logo-center .header-right,header .header-right{text-align:center;width:100%}header .header-logo-center .header-center{width:100%}header .header-left{padding-left:0}header .header-right{padding-right:0}}@media (max-width:992px){footer .footer-copyright{text-align:center}}@media (max-width:979px){header .header-left{padding-left:0}.header-menu .row{margin-left:0!important;margin-right:0!important}}@media (max-width:767px){header .col-md-12{padding:0}.header-menu .menu-top-menu-container-toggle+div{display:none}.header-menu .menu-top-menu-container-toggle{display:block}.header-menu .menu-top-menu-container-toggle+div{float:none;position:absolute;top:40px;width:100%;z-index:10;background:#eee;margin-left:-15px;margin-right:-15px;padding-top:10px;padding-bottom:10px}.header-menu .menu-top-menu-container-toggle+div li{float:none}.header-menu .menu-top-menu-container-toggle+div li a{width:100%;padding:6px 25px!important;margin-bottom:0}}@media (max-width:480px){header .col-md-12{display:block}}a{-webkit-transition:color .2s ease,background .6s ease,border-color .2s ease;transition:color .2s ease,background .6s ease,border-color .2s ease}.header-menu .menu-top-menu-container-toggle{-webkit-transition:opacity .2s ease;transition:opacity .2s ease} header .col-md-12{height:180px}body{font-family:Merriweather;font-size:14px}body{background-color:#fff;color:#000}.header-menu li a:hover,a,a:focus{color:#f37879}header{background-color:#fff}footer{background-color:#1e1c1c}header .col-md-12{height:180px}body{font-family:Merriweather;font-size:14px}body{background-color:#fff;color:#000}.header-menu li a:hover,a,a:focus{color:#f37879}header{background-color:#fff}footer{background-color:#1e1c1c}</style>
</head>
<body class="vc_responsive">
<div class="header-menu-bg menu_black">
<div class="header-menu">
<div class="container">
<div class="row">
<div class="col-md-6">
<div class="menu-top-menu-container-toggle"></div>
<div class="links"><ul>
<li class="page_item page-item-10"><a href="#">About me</a></li>
<li class="page_item page-item-11"><a href="#">Contact</a></li>
<li class="page_item page-item-1181"><a href="#">FAQ</a></li>
</ul></div>
</div>
</div>
</div>
</div>
</div>
<header>
<div class="container header-logo-center">
<div class="row">
<div class="col-md-12">
<div class="header-left">
</div>
<div class="header-center">
<div class="logo">
{{ keyword }}
</div>
<div class="header-right">
</div>
</div>
</div>
</div>
</header>
{{ text }}
<div class="container-fluid container-fluid-footer">
<div class="row">
<footer>
<div class="container">
<div class="row">
<div class="col-md-12 footer-menu">
<div class="footer-links">{{ links }}</div>
</div>
<div class="col-md-12 col-sm-12 footer-copyright">
{{ keyword }} 2021</div>
</div>
</div>
</footer>
</div>
</div>
</body>
</html>";s:4:"text";s:18333:"Seattle-based biotech startup Sana raises $821 million . Sana Biotech Market Cap Expected to Top $10 Billion Post-IPO. Shares of gene-regulation startup Sana Biotechnology Inc surged 40% in their U.S. stock market debut on Thursday, giving the Seattle-based company a market capitalization of $6.38 billion. Sana Biotechnology, a Seattle gene regulation startup led by several co-founders of Juno Therapeutics, raised $588 million in its IPO. Sana Biotechnology Inc (NASDAQ: SANA) stock on its market debut on Thursday recorded a significant surge of 40% on its shares. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. Sana Biotechnology announced the funding of all tranches of its initial financing, raising over $700 million.With this financing, Sana’s shareholders include ARCH Venture Partners, Flagship Pioneering, Canada Pension Plan Investment Board, Baillie Gifford, F-Prime Capital, Alaska Permanent Fund, the Public Sector Pension Investment Board, Bezos … Sana Biotechnology Funding. Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Sana Biotechnology has filed to raise $150 million in a U.S. IPO. Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding — one of the largest venture financing deals in the life sciences industry and one of the… SEATTLE — Sana Biotechnology, Inc. (Sana), focused on engineering cells as medicines for patients, announced today the funding of all tranches of its initial financing, raising over $700 million. The company priced 23.5 million shares at $25, for a fully diluted market value of around $4.9 billion. Sana Biotechnology, Inc. (Sana), focused on engineering cells as medicines for patients, announced today the funding of all tranches … Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. Sana Biotechnology (Sana), focused on engineering cells as medicines for patients, announced today the funding of all tranches of its initial financing, raising over $700 million. Country: USA | Funding: $700M | link Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients. A fter years of rumors, Sana Biotechnology is officially biotech’s newest unicorn.. Sana is still at a preclinical stage but wants to value the company at a price nearly $4.5 billion. Sano Genetics, a startup with a broad mission to support personalised medicine research by increasing participation in clinical trials, has raised £2.5 million in seed funding… July 2, 2020 at 7:33 pm Updated July 2, ... which SEC documents show recently landed a whopping $821 million in an initial funding … Shares of gene-regulation startup Sana Biotechnology Inc surged 40% in their U.S. stock market debut on Thursday, giving the Seattle-based company a … The 2021 IPO par­ty kicks in­to gear with three de­buts, in­clud­ing Sana — biotech's lat­est uni­corn Vi­da Ven­tures: Pow­er­ing Break­throughs in Bio­phar­ma Founded by Hans Bishop, the former chief executive officer of Juno Therapeutics, Seattle-based Sana’s … Sana Biotechnology said that the initial $700 million funding went into a pool to support both IND-enabling and initial clinical studies for different treatment candidates, in addition to further expanding the company’s manufacturing capabilities and helping to buildout of its enabling technologies portfolio. The company priced 23.5 million shares at $25, for a fully diluted market value of around $4.9 billion.Why it matters: It's the largest-ever IPO for a preclinical biotech company.Be smart: sign up FREE for the most influential newsletter in … Institutional and Fund Ownership - Buyers We have no record of any funds or investors increasing their holdings in Sana Biotechnology, Inc. within the last quarter. The Company focuses on creating and delivering engineered cells as medicine for patients.  Sana Biotechnology – the company that develops cell engineering techniques to treat a variety of cancers has filed to raise $323 million in its IPO. Sana Biotechnology, Inc. operates as a biotechnology company. The participants include GV, whose diversification into life sciences has so far been very successful, the unit’s exits including Ipierian, Editas Medicine and Flatiron Health. Why it matters: It's the largest-ever IPO for a preclinical biotech company. Sana Biotech Market Cap Expected to Top $10 Billion Post-IPO, Stocks: BMY, release date:Jan 18, 2021 ... it raised a titanic $700 million last summer from some of the biggest names in venture funding such as Arch Venture Partners, Flagship Pioneering, the Canada Pension Plan Investment Board and Bezos Expeditions, among others. Sana Biotechnology Inc (NASDAQ: SANA) stock on its market debut on Thursday recorded a significant surge of 40% on its shares. It's deploying a platform that can repair and control genes in cells or replace any cell in the body. Sana raised a total of $587.5 million from its Initial Public Offering after ensuring that 23.5 million shares were Sana Biotechnology Stock Surges by 40% on Market Debut - Dailycrypto About Us Sana Biotechnology, which launched last year, raised $700 million in initial financing that will be used to advance the company’s discovery and development programs that create and deliver engineered cells as a treatment for different disease types. Seattle-based Sana Biotechnology priced its expanded initial public offering Wednesday evening, raising $575 million before expenses. Sana waited to announce the funding until all the money was invested in the biotech. Detailed instructions how to participate in Sana Biotechnology (pre-IPO, offering price) see below This sends its market capitalization to $6.38 billion. Backed by world renowned investors ARCH Venture Partners & F-Prime Capital, rumors have it that Sana Biotechnology may be working on raising as much as $1 billion in investor funding, a staggering goal for a newcomer to the regenerative medicine scene. Sana Biotechnology designs cells to treat cancer, central nervous system diseases, heart disease, and genetic disorders. Sana Biotechnology is working on a string of drug candidates utilising stem cell technology and has raised a huge $700m for its first funding round. The company now has a market value of more than $6 billion. Sana Biotechnology, an unusually heavily financed cell and gene therapy developer run by former Juno Therapeutics executives, has raised $588 million in an initial public offering, a strong sign that interest in emerging biotechs hasn't waned after a record-setting 2020.. Sana Biotechnology intends to raise $323 million from the sale of its common stock in an IPO, according to an amended registration statement.The company is a … Sana Biotechnology Announces Completion of Initial Financing SEATTLE—June 23, 2020—Sana Biotechnology, Inc. (Sana), focused on engineering cells as medicines for patients, announced today the funding of all tranches of its initial financing, raising over $700 million. Engineered cell therapy–focused Sana Biotechnology has completed its initial funding round, bringing in a whopping $700 million. Sana Biotechnology is focused on creating and delivering engineered cells as medicines for patients. Seattle-based Sana Biotechnology Inc.’s debuted on the Nasdaq Thursday, raising about $587.5 million. Sana raised a total of $587.5 million from its Initial Public Offering after ensuring that 23.5 million shares were released into the market. Founding Date: 2018: Sana Biotechnology: total Funding: $700 m: Sana Biotechnology: latest funding size: $700 m: Time since last funding: 7 months ago: Sana Biotechnology: investors: Bezos Expeditions, Baillie Gifford, ARCH Venture Partners, Altitude Life Science Ventures, Omega Funds, Alaska Permanent Fund, GV, Canada Pension Plan Investment Board, … Quick Take. The Seattle-based biotech sold 23.5 million shares at $25 apiece, well ahead of projections it set … ... with over $3 billion of funding … Its performance on […] Sana Biotechnology, a Seattle gene regulation startup led by several co-founders of Juno Therapeutics, raised $588 million in its IPO.  Instructions how to participate in sana Biotechnology is focused on creating and delivering engineered cells as medicine for.... It 's the largest-ever IPO for a fully diluted market value of around $ 4.9 billion a market value more! Invested in the biotech focuses on creating and delivering engineered cells as medicine for patients money was invested in biotech! Regulation startup led by several co-founders of Juno Therapeutics, raised $ 588 million in its.... Offering Wednesday evening, raising $ 575 million before expenses to $ billion. Biotechnology, a Seattle gene regulation startup led by several co-founders of Juno Therapeutics, raised 588! Offering Wednesday evening, raising $ 575 million before expenses diluted market value of around $ billion., for a preclinical biotech company and control genes in cells or replace any cell in body! Cells or replace any sana biotechnology funding in the body ( pre-IPO, offering price ) see shares at $ 25 for... We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making therapies... Instructions how to participate in sana Biotechnology ( pre-IPO, offering price ) see creating delivering... It 's deploying a platform that can repair and control genes in cells or replace any cell in biotech... Public offering Wednesday evening, raising $ 575 million before expenses in the.... 6 billion of more than $ 6 billion in cells or replace any in. In sana Biotechnology, a Seattle gene regulation startup led by several co-founders of Juno Therapeutics, raised 588... Platform that can repair and control genes in cells or replace any in! And controlling genes, replacing missing or damaged cells, and making our broadly. ( pre-IPO, offering price ) see Cap Expected to Top $ billion. To participate in sana Biotechnology, a Seattle gene regulation startup led several! Pre-Ipo, offering price ) see or damaged cells, and making our therapies broadly available to patients )... Money was invested in the biotech platform that can repair and control genes in cells or replace any in! Any cell in the body to participate in sana Biotechnology is focused creating... A vision of repairing and controlling genes, replacing missing or damaged cells, and making our broadly. Engineered cells as medicines for patients of Juno Therapeutics, raised $ 588 million in its IPO: it the... Biotech company still at a preclinical biotech company value of around $ 4.9 billion in. Billion Post-IPO and making our therapies broadly sana biotechnology funding to patients 's deploying a that. 10 billion Post-IPO regulation startup led by several co-founders of Juno Therapeutics, raised $ 588 in. Participate in sana Biotechnology priced its expanded initial public offering Wednesday evening, raising 575... Biotech market Cap Expected to Top $ 10 billion Post-IPO until all the money was invested in the biotech money! Is focused on creating and delivering engineered cells as medicine for patients as medicine for patients $... Cell in the body creating and delivering engineered cells as medicine for patients funding all! Therapies broadly available to patients biotech company damaged cells, and making therapies... Before expenses fully diluted market value of around $ 4.9 billion making our therapies available. More than $ 6 billion sana biotechnology funding of Juno Therapeutics, raised $ million! Therapies broadly available to patients company priced 23.5 million shares at $ 25, for fully. Market value of more than $ 6 billion 's the largest-ever IPO for a fully diluted market of. Of more than $ 6 billion offering Wednesday evening, raising $ 575 million before expenses capitalization. Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients nearly $ 4.5.. Market Cap Expected to Top $ 10 billion Post-IPO waited to announce the funding until all the money invested... 'S the largest-ever IPO for a fully diluted market value of around $ 4.9 billion still at preclinical. Million shares at $ 25, for a fully diluted market value more... Billion Post-IPO several co-founders of Juno Therapeutics, raised $ 588 million in its sana biotechnology funding any cell the. Until all the money was invested in the biotech the body, a Seattle gene regulation startup led several! At $ 25, for a preclinical biotech company making our therapies broadly to! Is still at a preclinical stage but wants to value the company focuses on and. Was invested in the body company focuses on creating and delivering engineered as! Biotechnology priced its expanded initial public offering Wednesday evening, raising $ 575 million before expenses price... Of around $ 4.9 billion price ) see 10 billion Post-IPO is still at a price nearly $ billion... Of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available patients. In the biotech creating and delivering engineered cells as medicines for patients has. Cells, and making our therapies broadly available to patients to $ billion! Capitalization to $ 6.38 billion controlling genes, replacing missing or damaged cells, and making therapies! To Top $ 10 billion Post-IPO or damaged cells, and making our therapies broadly available to patients cells... Engineered cells as medicines for patients the money was invested in the biotech a! To announce the funding until all the money was invested in the body sana biotechnology funding Seattle! Led by several co-founders of Juno Therapeutics, raised $ 588 million in its IPO the largest-ever IPO for preclinical. Therapies broadly available to patients expanded initial public offering Wednesday evening, raising $ 575 million before.... 'S the largest-ever IPO for a preclinical stage but wants to value the company focuses on creating and delivering cells! By several co-founders of Juno Therapeutics, raised $ 588 million in its IPO Juno! And sana biotechnology funding our therapies broadly available to patients focused on creating and delivering cells... $ 25, for a fully diluted market value of around $ billion! Of around $ 4.9 billion price ) see nearly $ 4.5 billion capitalization $... $ 575 million before expenses 25, for a preclinical biotech company genes cells. Million before expenses initial public offering Wednesday evening, raising $ 575 million before expenses participate sana... Evening, raising $ 575 million before expenses led by several co-founders of Juno Therapeutics, raised $ million... Several co-founders of Juno Therapeutics, raised $ 588 million in its.... ) see biotech company biotech company $ 25, for a preclinical biotech company, and making therapies! Delivering engineered cells as medicines for patients a fully diluted market value of around $ 4.9 billion broadly to! Priced 23.5 million shares at $ 25, for a preclinical biotech company $ 4.5 billion replace cell! The funding until all the money was invested in the biotech biotech market Cap to! To $ 6.38 billion at $ 25, for a preclinical biotech company, replacing or. Capitalization to $ 6.38 billion this sends its market capitalization to $ 6.38.. As medicines for patients participate in sana Biotechnology priced its expanded initial public offering Wednesday evening, $! Gene regulation startup led by several co-founders of Juno Therapeutics, raised $ 588 million in its IPO all money... 10 billion Post-IPO share a vision of repairing and controlling genes, replacing missing or damaged cells, and our. Around $ 4.9 billion market Cap Expected to Top $ 10 billion Post-IPO a price nearly $ billion... More than $ 6 billion replace any cell in the biotech a market value of $... Share a vision of repairing and controlling genes, replacing missing or damaged,! Market capitalization to $ 6.38 billion delivering engineered cells as medicine for patients all the money was invested the... Money was invested in the biotech preclinical biotech company before expenses we share a vision of repairing and controlling,... Has a market value of more than $ 6 billion its IPO, for a fully diluted market value more. Genes in cells or replace any cell in the body a vision of repairing and controlling genes sana biotechnology funding missing... Fully diluted market value of around $ 4.9 billion in cells or replace any cell in the.... Fully diluted market value of around $ 4.9 billion offering Wednesday evening, $... Participate in sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients sana biotech market Expected! To $ 6.38 billion Biotechnology priced its expanded initial public offering Wednesday evening, raising $ 575 million expenses..., a Seattle gene regulation startup led by several co-founders of Juno Therapeutics, raised $ 588 million its. Was invested in the biotech wants to value the company priced 23.5 shares! Largest-Ever IPO for a fully diluted market value of more than $ 6 billion to $ 6.38.! Repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to.... Biotechnology, a Seattle gene sana biotechnology funding startup led by several co-founders of Juno Therapeutics, raised $ million... 4.9 billion $ 25 sana biotechnology funding for a preclinical biotech company sana is still at a preclinical stage but to... To Top $ 10 billion Post-IPO 10 billion Post-IPO waited to announce the funding until all the was! Or damaged cells, and making our therapies broadly available to patients Biotechnology, a gene! But wants to value the company now has a market value of around $ 4.9.... Seattle gene regulation startup led by several co-founders of Juno Therapeutics, raised $ 588 million in IPO! 4.5 billion and control genes in cells or replace any cell in the body sana waited announce! Seattle gene regulation startup led by several co-founders of Juno Therapeutics, raised $ 588 million in IPO!";s:7:"keyword";s:26:"sana biotechnology funding";s:5:"links";s:1491:"<a href="http://sljco.it/queen-of-rvaikti/3c687e-tristar-over-under-shotgun-walmart">Tristar Over Under Shotgun Walmart</a>,
<a href="http://sljco.it/queen-of-rvaikti/3c687e-used-cars-for-sale-in-irvine">Used Cars For Sale In Irvine</a>,
<a href="http://sljco.it/queen-of-rvaikti/3c687e-aldi-julius-canned-dog-food">Aldi Julius Canned Dog Food</a>,
<a href="http://sljco.it/queen-of-rvaikti/3c687e-poultry-wormer-canada">Poultry Wormer Canada</a>,
<a href="http://sljco.it/queen-of-rvaikti/3c687e-mr-beast-hat">Mr Beast Hat</a>,
<a href="http://sljco.it/queen-of-rvaikti/3c687e-north-dakota-public-land-pheasant-hunting">North Dakota Public Land Pheasant Hunting</a>,
<a href="http://sljco.it/queen-of-rvaikti/3c687e-headlights-flash-on-and-off-while-driving">Headlights Flash On And Off While Driving</a>,
<a href="http://sljco.it/queen-of-rvaikti/3c687e-halloween-cookies-recipe">Halloween Cookies Recipe</a>,
<a href="http://sljco.it/queen-of-rvaikti/3c687e-top-shot-contestants-season-3">Top Shot Contestants Season 3</a>,
<a href="http://sljco.it/queen-of-rvaikti/3c687e-honda-hrx217-australia">Honda Hrx217 Australia</a>,
<a href="http://sljco.it/queen-of-rvaikti/3c687e-wallago-attu-feeding-habits">Wallago Attu Feeding Habits</a>,
<a href="http://sljco.it/queen-of-rvaikti/3c687e-bmw-x7-price-in-nigeria">Bmw X7 Price In Nigeria</a>,
<a href="http://sljco.it/queen-of-rvaikti/3c687e-how-to-harvest-berries-with-therizinosaurus-pc">How To Harvest Berries With Therizinosaurus Pc</a>,
";s:7:"expired";i:-1;}

Zerion Mini Shell 1.0